Send the following on WhatsApp
Continue to Chat楊森藥廠一日雙喜!多發性骨髓瘤藥物 Tecvayli、兒童移植感染疾病治療 Imbruvica 獲核准 https://geneonline.news/janssen-tecvayli-imbruvica/
楊森藥廠一日雙喜!多發性骨髓瘤藥物 Tecvayli、兒童移植感染疾病治療 Imbruvica 獲核准 https://geneonline.news/janssen-tecvayli-imbruvica/